THE Central Government Thursday extended the gap between two doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks based on the recommendation of the COVID Working Group..No change in the interval of the COVAXIN vaccine doses has been recommended..The COVID Working Group is chaired by Dr N K Arora..Based on available real-life evidence, particularly from the UK, the COVID-19 Working Group has agreed to increase the dosing interval to 12-16 weeks between two doses of the Covishield vaccine, a government statement said..The COVID Working Group comprises the following members:.Dr N K Arora- Director, INCLEN TrustDr Rakesh Agarwal, Director and dean, GIPMER, PuducherryDr Gagandeep Kang, professor, Christian Medical College, VelloreDr J P Mulliyal, Retd professor, Christian Medical College, VelloreDr Naveen Khanna, Group Leader, International Centre For Genetic Engineering And Biotechnology (ICGEB), JNU, New DelhiDr Amulya Panda, Director, National Institute of Immunology, New DelhiDr V G Somani, Drugs Controller General of India (DCGI), Govt of India.The recommendation of the COVID Working Group was accepted by the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), headed by Dr V K Paul, Member (Health) Niti Aayog in its meeting on 12th May 2021.
THE Central Government Thursday extended the gap between two doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks based on the recommendation of the COVID Working Group..No change in the interval of the COVAXIN vaccine doses has been recommended..The COVID Working Group is chaired by Dr N K Arora..Based on available real-life evidence, particularly from the UK, the COVID-19 Working Group has agreed to increase the dosing interval to 12-16 weeks between two doses of the Covishield vaccine, a government statement said..The COVID Working Group comprises the following members:.Dr N K Arora- Director, INCLEN TrustDr Rakesh Agarwal, Director and dean, GIPMER, PuducherryDr Gagandeep Kang, professor, Christian Medical College, VelloreDr J P Mulliyal, Retd professor, Christian Medical College, VelloreDr Naveen Khanna, Group Leader, International Centre For Genetic Engineering And Biotechnology (ICGEB), JNU, New DelhiDr Amulya Panda, Director, National Institute of Immunology, New DelhiDr V G Somani, Drugs Controller General of India (DCGI), Govt of India.The recommendation of the COVID Working Group was accepted by the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), headed by Dr V K Paul, Member (Health) Niti Aayog in its meeting on 12th May 2021.
